What Pharmaceutical Product Patents Might Mean for India
This article was originally published in SRA
Executive Summary
Rashmi Kulshrestha, B Vijayaraghavan, Priyamvada Singh and Arun Kumar discuss the likely impact of the 2004 Patents (Amendment) Ordinance on the Indian pharmaceutical sector.